Top ▲
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Target id: 2163
Nomenclature: phosphatidylinositol-5-phosphate 4-kinase type 2 gamma
Abbreviated Name: PIP4K2C
Family: Phosphatidylinositol phosphate kinases, Type II PIP kinases (1-phosphatidylinositol-5-phosphate 4-kinase family)
Gene and Protein Information ![]() |
||||||
| Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
| Human | - | 421 | 12q13.3 | PIP4K2C | phosphatidylinositol-5-phosphate 4-kinase type 2 gamma | |
| Mouse | - | 421 | 10 D3 | Pip4k2c | phosphatidylinositol-5-phosphate 4-kinase, type II, gamma | |
| Rat | - | 420 | 7q22 | Pip4k2c | phosphatidylinositol-5-phosphate 4-kinase type 2 gamma | |
Database Links ![]() |
|
| Alphafold | Q8TBX8 (Hs), Q91XU3 (Mm), O88370 (Rn) |
| BRENDA | 2.7.1.149 |
| CATH/Gene3D | 3.30.800.10, 3.30.810.10 |
| ChEMBL Target | CHEMBL1770034 (Hs) |
| Ensembl Gene | ENSG00000166908 (Hs), ENSMUSG00000025417 (Mm), ENSRNOG00000005138 (Rn) |
| Entrez Gene | 79837 (Hs), 117150 (Mm), 140607 (Rn) |
| Human Protein Atlas | ENSG00000166908 (Hs) |
| KEGG Enzyme | 2.7.1.149 |
| KEGG Gene | hsa:79837 (Hs), mmu:117150 (Mm), rno:140607 (Rn) |
| Pharos | Q8TBX8 (Hs) |
| RefSeq Nucleotide | NM_001146258 (Hs), NM_054097 (Mm), NM_080480 (Rn) |
| RefSeq Protein | NP_001139730 (Hs), NP_473438 (Mm), NP_536728 (Rn) |
| UniProtKB | Q8TBX8 (Hs), Q91XU3 (Mm), O88370 (Rn) |
| Wikipedia | PIP4K2C (Hs) |
Selected 3D Structures ![]() |
|||||||||||
|
|
||||||||||
Enzyme Reaction ![]() |
||||
|
||||
| Other Binding Ligands | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
DiscoveRx KINOMEscan® screen ![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 1,3 |
![]()
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Target used in screen: PIP5K2C | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displaying the top 10 most potent ligands View all ligands in screen » | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
2. Good A, Brown K, Goodman KB, Ye G, O'Shea M. (2024) Inhibitors and degraders of pip4k protein. Patent number: WO2024233846A1. Assignee: Larkspur Biosciences, Inc.. Priority date: 09/05/2024. Publication date: 14/11/2024.
3. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
Phosphatidylinositol phosphate kinases: phosphatidylinositol-5-phosphate 4-kinase type 2 gamma. Last modified on 08/09/2025. Accessed on 25/10/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=2163.